Showing results (101-110 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|March 15, 2021
The safety and efficacy of immune-checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseasesChunlan Wu, Li Zhong, Qing Wu, et al.Immunotherapy|September 13, 2022
Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech RepublicBarbora Turková, Jan Tužil, Barbora Pilnáčková, et al.Immunotherapy|September 13, 2022
Efficacy of long-term repeated rituximab treatment in refractory phospholipase A2 receptor-antibody-related membranous nephropathyLihua Zhang, Mengxing Chen, Weibo Le, et al.Immunotherapy|June 13, 2015
Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppressionPaul A Beavis, Clare Y Slaney, Michael H Kershaw, et al.Immunotherapy|June 13, 2015
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumorsHinrich AbkenImmunotherapy|June 13, 2015
Exploiting cytokines in adoptive T-cell therapy of cancerElisabetta Petrozziello, Tabea Sturmheit, Anna MondinoImmunotherapy|June 4, 2020
Asthma immunotherapy and treatment approaches with mesenchymal stem cellsTunç Akkoç, Deniz GençImmunotherapy|August 23, 2021
Plasmodium falciparum-infected humanized mice: a viable preclinical toolRajeev K TyagiImmunotherapy|May 28, 2020
Ear and labyrinth toxicities induced by immune checkpoint inhibitors: a disproportionality analysis from 2014 to 2019Fangyuan Hu, Xiaofei Ye, Yinghong Zhai, et al.Immunotherapy|August 4, 2022
The latest developments in biomarkers predicting response to immunotherapyGiandomenico Roviello, Melissa Bersanelli, Martina CatalanoPageof 188